Fortress Biotech, Inc. (FBIO)
2.52
-0.05
(-1.95%)
USD |
NASDAQ |
Sep 11, 16:00
2.535
+0.02
(+0.60%)
After-Hours: 20:00
Fortress Biotech Price : 2.52 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 2.59 | 2.625 | 2.52 | 2.52 | 209700.0 |
| Sep 10, 2026 | 2.60 | 2.625 | 2.53 | 2.57 | 315547.0 |
| Sep 09, 2026 | 2.67 | 2.70 | 2.62 | 2.63 | 280402.0 |
| Sep 08, 2026 | 2.69 | 2.75 | 2.67 | 2.71 | 263047.0 |
| Sep 04, 2026 | 2.68 | 2.74 | 2.675 | 2.72 | 168144.0 |
| Sep 03, 2026 | 2.75 | 2.76 | 2.695 | 2.71 | 148110.0 |
| Sep 02, 2026 | 2.67 | 2.74 | 2.67 | 2.73 | 279774.0 |
| Sep 01, 2026 | 2.69 | 2.77 | 2.63 | 2.68 | 605781.0 |
| Aug 31, 2026 | 2.795 | 2.795 | 2.69 | 2.735 | 326338.0 |
| Aug 28, 2026 | 2.80 | 2.81 | 2.745 | 2.77 | 309687.0 |
| Aug 27, 2026 | 2.84 | 2.875 | 2.77 | 2.80 | 463477.0 |
| Aug 26, 2026 | 2.79 | 2.88 | 2.78 | 2.81 | 395827.0 |
| Aug 25, 2026 | 2.95 | 2.990 | 2.78 | 2.83 | 451343.0 |
| Aug 24, 2026 | 2.83 | 2.99 | 2.83 | 2.93 | 603897.0 |
| Aug 21, 2026 | 2.80 | 2.875 | 2.794 | 2.87 | 202716.0 |
| Aug 20, 2026 | 2.80 | 2.87 | 2.75 | 2.77 | 323759.0 |
| Aug 19, 2026 | 2.93 | 2.93 | 2.79 | 2.85 | 536560.0 |
| Aug 18, 2026 | 2.82 | 2.91 | 2.76 | 2.91 | 593190.0 |
| Aug 17, 2026 | 2.89 | 2.896 | 2.730 | 2.82 | 838777.0 |
| Aug 14, 2026 | 2.92 | 3.02 | 2.71 | 2.93 | 1.032M |
| Aug 13, 2026 | 2.76 | 3.055 | 2.70 | 2.98 | 1.394M |
| Aug 12, 2026 | 2.61 | 2.78 | 2.57 | 2.75 | 1.008M |
| Aug 11, 2026 | 2.74 | 2.74 | 2.60 | 2.61 | 617236.0 |
| Aug 10, 2026 | 2.66 | 2.790 | 2.63 | 2.75 | 542785.0 |
| Aug 07, 2026 | 2.77 | 2.85 | 2.65 | 2.67 | 579991.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.25 |
| Kura Oncology, Inc. | 11.39 |
| Spero Therapeutics, Inc. | 1.13 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
Price Related Metrics
| PE Ratio | 0.9486 |
| PS Ratio | 1.239 |
| Price to Book Value | 0.5114 |
| Price to Free Cash Flow | 0.7054 |
| Earnings Yield | 105.4% |
| Market Cap | 83.94M |
| Normalized PE Ratio | 1.029 |